Evidence map›Paper›PMID 41372282›Full record

ArticleScientific reports2025

Early diagnosis of alzheimer's disease using PET imaging and deep learning with comparative data augmentation techniques.

Muhammad Athar, Ahsan Bin Tufail, Tahir Alyas, Andrea Stevens Karnyoto, Muhammad Sheeraz, Aidarus Mohamed Ibrahim, Taher M Ghazal

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Muhammad AtharUniversity of Engineering and Technology, Lahore, Pakistan.
Ahsan Bin TufailDepartment of Computer Science, The University of Chenab, Gujrat, Pakistan.
Tahir AlyasDepartment of Computer Science, Lahore Garrison University, Lahore, Pakistan.
Andrea Stevens KarnyotoDepartment of Computer Science, BINUS Graduate Program, Master of Computer Science, Bina Nusantara University, Jakarta, 11480, Indonesia.
Muhammad SheerazBarani Institute of Information Technology, Rawalpindi, Pakistan.
Aidarus Mohamed IbrahimCollege of Computing & IT, University of Hargeisa, Hargeisa, Somalia. aidarus.ibrahim@uoh.edu.so.
Taher M GhazalFaculty of Computing and IT, Sohar University, Sohar, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's Disease (AD) is a neurological disorder affecting the functioning of central nervous system. It can lead to poor coordination, seizures and paralysis. Neuroimaging modalities such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) can provide important information about AD and will continue to do so in the future as far as clinical manifestations of this disease are concerned. Information from neuroimaging modalities can be combined with deep learning (DL) approaches to diagnose AD in its early stages, reducing the burden on neuropathologists. In this study, we compared the performances of six data augmentation methods -ellipsoidal averaging, Laplacian of Gaussian (LoG), local Laplacian, local contrast, Prewitt-edge emphasising, and unsharp masking -on AD diagnosis. We studied three binary problems: AD-Normal Control (NC), AD-Mild Cognitive Impairment (MCI), and MCI-NC, and one multiclass (3-classes) classification problem: AD-MCI-NC. We also combined these data augmentation methods and tried a strided convolution architecture for these tasks. We find that Prewitt-edge emphasising augmentation yields the best performance for AD-MCI-NC and AD-MCI classification tasks. In contrast, local Laplacian augmentation performs the best for the MCI-NC classification task, while LoG augmentation yields the best results for the AD-NC classification task.

Indexed as

Alzheimer DiseaseDeep LearningPositron-Emission TomographyAgedAged, 80 and overBrainCognitive DysfunctionEarly DiagnosisFemaleHumansMagnetic Resonance ImagingMaleNeuroimaging

Identifiers

PMID41372282
PMCPMC12779952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.